يعرض 31 - 32 نتائج من 32 نتيجة بحث عن '"Iris T Chan"', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 31
    Abstract LB-89: Clinical combination of the MEK inhibitor GDC-0973 and the PI3K inhibitor GDC-0941: A first-in-human phase Ib study in patients with advanced solid tumors

    المؤلفون: Luna Musib, Johanna C. Bendell, Patricia LoRusso, Mary Gates, Susan Pandya, Meghan McKenzie, Eunice Kwak, Marcia Belvin, Cheryl Jones, Geoffrey I. Shapiro, Alex de Crespigny, Iris T. Chan

    المصدر: Cancer Research. 71:LB-89

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Melanoma, MEK inhibitor, Cancer, Pharmacology, medicine.disease, medicine.disease_cause, Dysgeusia, Prostate cancer, Tolerability, Internal medicine, medicine, KRAS, medicine.symptom, Adverse effect, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::297c6249f5903de46b480e5fb6de912dTest
    https://doi.org/10.1158/1538-7445.am2011-lb-89Test


    أضف إلى المفضلة
  2. 32
    Abstract 4716: A first-in-human phase 1 study to evaluate the MEK1/2 inhibitor GDC-0973 administered daily in patients with advanced solid tumors

    المؤلفون: Wen Wee Ma, Patricia LoRusso, Branimir I. Sikic, Johathan Goldman, Stuart Johnston, Salim Yazji, Cheryl Jones, Iris T. Chan, Amy Weise, Luna Musib, Lee S. Rosen, Alex A. Adjei, A. Dimitrios Colevas, Mary Gates, Angela Shen, Alex de Crespigny

    المصدر: Cancer Research. 71:4716-4716

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Nausea, Cmax, Pharmacology, Gastroenterology, Rash, Oncology, Pharmacokinetics, Internal medicine, Pharmacodynamics, medicine, Vomiting, Dosing, medicine.symptom, business, Adverse effect

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::54be58da08b3fb0d3219cb3995c192aaTest
    https://doi.org/10.1158/1538-7445.am2011-4716Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث